Literature DB >> 25424426

Arg972 insulin receptor substrate-1 polymorphism and risk and severity of rheumatoid arthritis.

Hongjun Zhao1, Shiqing Liu1, Mei Long1, Lijuan Peng1, Hongxiang Deng1, Yunhui You1.   

Abstract

AIM: To explore the association between the Arg(972) insulin receptor substrate (IRS)-1 polymorphism (rs1801278) and the risk and disease activity/severity of rheumatoid arthritis (RA).
METHOD: We genotyped the Arg(972) IRS-1 polymorphism in 871 pairs of age-, sex-, body mass index-, residence area- and current smoking status-matched RA patients and controls. We assessed RA severity using the disease activity score of 28 joints (DAS28).
RESULTS: The AA (homozygous Arg(972) IRS-1) and GA (heterozygous Arg(972) IRS-1) genotypes were significantly associated with high risk of RA with or without adjustment for comorbidities (P < 0.001). The A allele was significantly associated with high risk of RA (P < 0.001). The AA genotype was significantly associated with high/severe RA activity (P < 0.001), while the GG genotype (wild type IRS-1) had protective effects.
CONCLUSION: The Arg(972) IRS-1 polymorphism is associated with increased risk and disease activity/severity of RA, and therefore may be a potential prognostic factor for RA. This study adds novel insights into the pathogenesis of RA.
© 2014 Asia Pacific League of Associations for Rheumatology and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  disease activity score of 28 joints (DAS28); gene polymorphism; insulin receptor substrate-1; insulin resistance; rheumatoid arthritis

Mesh:

Substances:

Year:  2014        PMID: 25424426     DOI: 10.1111/1756-185X.12366

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  2 in total

Review 1.  Genetic markers predicting sulphonylurea treatment outcomes in type 2 diabetes patients: current evidence and challenges for clinical implementation.

Authors:  N K Loganadan; H Z Huri; S R Vethakkan; Z Hussein
Journal:  Pharmacogenomics J       Date:  2016-01-26       Impact factor: 3.550

2.  SLAMF6 is associated with the susceptibility and severity of rheumatoid arthritis in the Chinese population.

Authors:  Guodong Xia; Yetian Li; Wei Pan; Chengmei Qian; Lin Ma; Jingli Zhou; Henggui Xu; Chen Cheng
Journal:  J Orthop Surg Res       Date:  2022-01-11       Impact factor: 2.359

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.